The diagnosis of a substance or opioid use disorder during pregnancy is linked to complications for the mother, fetus, and newborn. Chronically drug exposed fetuses are at high risk for neonatal abstinence syndrome (NAS) or neonatal opioid withdrawal syndrome (NOWS). Anywhere from 45% to 94% of infants exposed in utero can show signs of withdrawal. From the first hour of life and up to 6 months postpartum, NAS/NOWS may evolve. This activity is part two of a two-part series that explores the evidence-based care of newborns who are at high risk for NAS/NOWS.
- Provider:LAMMICO/Medical Interactive
- Activity Link: https://www.medicalinteractive.com/courses/51746
- Start Date: 2024-06-03 05:00:00
- End Date: 2024-06-03 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Pediatrics, Hospital Medicine, Neonatal-Perinatal Medicine
Warning: file_put_contents(/nas/content/live/sleepliteracy/wp-content/uploads/wpdiscuz/cache/comments/.htaccess): Failed to open stream: Permission denied in /nas/content/live/sleepliteracy/wp-content/plugins/wpdiscuz/utils/class.WpdiscuzCache.php on line 161